Neurology News

CMS has proposed a National Coverage Determination decision memorandum specifying “coverage with evidence development” for FDA-approved monoclonal antibodies targeting amyloid for treating Alzheimer’s disease.

Neuroimaging company Imeka announced it has partnered with Atara Biotherapeutics Inc. to use Imeka’s novel biomarker technology in a phase 2 clinical study of individuals with progressive forms of MS.

Diagnoses of cardiovascular issues plateaued during the COVID-19 pandemic, but diagnoses of cerebrovascular issues dropped sharply compared with pre-pandemic levels, per a population-based study published in Neurology.

Clinics that provide timely care for patients with transient ischemic attacks can be an effective alternative to hospitalization in the prevention of future incidence of stroke, according to a systematic review and meta-analysis published in JAMA Network Open.

Neuroscience specialty pharmaceutical company OWP Pharmaceuticals Inc. has partnered with Eversana, a provider of global services to the life sciences industry, to launch oral liquid formulations for treating neuroscience disorders.

The FDA granted approval to Quviviq to treat adults with insomnia.

The Self-Administered Gerocognitive Examination identified signs of dementia in patients 6 months earlier than the Mini-Mental State Examination, according to results from a cohort study published in Alzheimer's Research & Therapy.

The number of people with dementia worldwide could increase 166%, from about 57.4 million people in 2019 to 152.8 million people in 2050, data from the Global Burden of Diseases, Injuries and Risk Factors Study showed.

The risk for cerebral venous sinus thrombosis within 28 days of receiving a first dose of a vector-based COVID-19 vaccine was higher in younger age groups among European populations, according to a study published in Neurology.

Compared with manual contact catheters, robotic magnetic navigation reduced risk for silent cerebral embolism after atrial fibrillation ablation procedures, researchers reported in Frontiers in Cardiovascular Medicine.